Human Papillomavirus News and Research RSS Feed - Human Papillomavirus News and Research

TOSH Program aims to improve oral-systemic health

TOSH Program aims to improve oral-systemic health

Improving oral health is a leading population health goal; however, curricula preparing health professionals have a dearth of oral health content and clinical experiences. Funded by a grant from the Health Resources and Service Administration, New York University College of Nursing's Teaching Oral-Systemic Health Program is working to build interprofessional oral health workforce capacity which addresses a significant public health issue, increases oral health care access, and improves oral-systemic health across the lifespan. [More]
UTMB study reveals that only about half of teenage girls get HPV vaccine at the recommended age

UTMB study reveals that only about half of teenage girls get HPV vaccine at the recommended age

It's a virus that is responsible for almost all cases of cervical cancer but a new study by University of Texas Medical Branch at Galveston researchers indicates that only about half of the girls receive the vaccine at the recommended age to best protect themselves. [More]
Two medical organizations recommend use of HPV test for cervical cancer screening

Two medical organizations recommend use of HPV test for cervical cancer screening

Two leading medical organizations say that using a Human papillomavirus (HPV) test alone for cervical cancer screening is an effective alternative to the current recommendation for screening with either cytology (the Pap test) alone or co-testing with cytology and HPV testing. [More]
New guidance recommends use of primary HPV test for cervical cancer screening

New guidance recommends use of primary HPV test for cervical cancer screening

About 80 million U.S. women ages 25 to 65 should be screened periodically by their health care providers for cervical cancer. At present, the standard way to do that is a Pap smear alone, or co-testing using both a Pap smear and a human papillomavirus (HPV) test. [More]
Quadrivalent HPV vaccine cleared of multiple sclerosis risk

Quadrivalent HPV vaccine cleared of multiple sclerosis risk

A study of almost 4 million girls and women allays fears that receipt of the quadrivalent human papillomavirus vaccine could increase the risk of developing multiple sclerosis, or other demyelinating disorders. [More]
Study sheds light on common psychosocial barriers affecting HPV vaccination in Puerto Rico

Study sheds light on common psychosocial barriers affecting HPV vaccination in Puerto Rico

Young Puerto Rican women and their mothers know little about the human papillomavirus (HPV) and cervical cancer, according to researchers at The University of Texas Health Science Center at Houston School of Public Health. [More]
Empathic partnership: A health care model for marginalized populations

Empathic partnership: A health care model for marginalized populations

Sitting on an exam table in a flimsy gown can intimidate anyone. If you also happen to be lesbian, gay or bisexual, the experience can be even worse. [More]
MRIGlobal awarded $3 million contract to provide HPV vaccine

MRIGlobal awarded $3 million contract to provide HPV vaccine

MRIGlobal today announced that it has been awarded a $3 million contract amendment from the National Cancer Institute's PREVENT Cancer Program to provide a vaccine for the Human Papillomavirus or HPV, the most common sexually transmitted infection in the United States. MRIGlobal will lead a team that will produce the vaccine to be used in a Phase I clinical trial. [More]
New WHO guidance provides cervical cancer control and prevention approach

New WHO guidance provides cervical cancer control and prevention approach

New guidance from WHO aims to help countries better prevent and control cervical cancer. The disease is one of the world's deadliest - but most easily preventable - forms of cancer for women, responsible for more than 270 000 deaths annually, 85% of which occur in developing countries. [More]
UNM Cancer Center program to help new scientists learn nuances of conducting science

UNM Cancer Center program to help new scientists learn nuances of conducting science

create a set of systems to track people, projects and money. But scientists' formal training doesn't always include business classes. To bridge this gap, Michelle Ozbun, PhD, at the University of New Mexico Cancer Center, is improving a program that helps new scientists learn nuances of conducting science. [More]
McGill study helps identify people at risk for oral human papillomavirus

McGill study helps identify people at risk for oral human papillomavirus

Oral human papillomavirus (HPV) infections were more common among men who had female partners with oral and/or genital HPV infection, suggesting that the transmission of HPV occurs via oral-oral and oral-genital routes, according to a McGill University study published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research. [More]
Eight million US women skip cervical cancer screening in the past five years

Eight million US women skip cervical cancer screening in the past five years

Despite evidence that cervical cancer screening saves lives, about eight million women ages 21 to 65 years have not been screened for cervical cancer in the past five years, according to a new Vital Signs report from the Centers for Disease Control and Prevention. More than half of new cervical cancer cases occur among women who have never or rarely been screened. [More]
NCI supports further clinical development of next-generation HPV vaccine

NCI supports further clinical development of next-generation HPV vaccine

The National Cancer Institute in the USA is supporting the new vaccine developed at the MedUni Vienna against the human papillomavirus (HPV) with at least US$ 3.5 million. This is a major success for the developers and means that the foundations can now be laid for the clinical trials needed for licensing as a vaccine. [More]

Japanese mushroom extract shows promise in eradicating HPV

A Japanese mushroom extract appears to be effective for the eradication of human papillomavirus (HPV), according to a pilot clinical trial at The University of Texas Health Science Center at Houston Medical School. [More]
Population Council to present research on novel approaches to HIV prevention at HIV R4P 2014

Population Council to present research on novel approaches to HIV prevention at HIV R4P 2014

The Population Council will present new research on novel approaches to HIV, sexually transmitted infections (STIs), and unintended pregnancy prevention at the HIV Research for Prevention Conference, (HIV R4P) in Cape Town, South Africa. HIV R4P, which runs 28–31 October, is the first global scientific meeting dedicated exclusively to research on biomedical HIV prevention. [More]
Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has signed an option for a license agreement with the world-renowned German Center for Cancer Research (DKFZ – Deutsches Krebsforschungszentrum), based in Heidelberg. The financial terms of the agreement were not disclosed. [More]
Tobacco use linked to oral HPV-16

Tobacco use linked to oral HPV-16

Study participants who reported tobacco use or had higher levels of biomarkers of tobacco exposure had a higher prevalence of the sexually transmitted infection, oral human papillomavirus type 16 (HPV-16), according to a study in the October 8 JAMA, a theme issue on infectious disease. [More]
Penn Medicine to explore therapeutic strategies for HIV positive women at risk of cervical cancer

Penn Medicine to explore therapeutic strategies for HIV positive women at risk of cervical cancer

The introduction of antiretroviral drugs in Botswana over the last two decades has increased the life expectancies of people living with HIV—many of whom are women co-infected with the human papillomavirus virus (HPV)—considerably: from 39 years to the low 60s. As a result, this co-infected group of women is at a much higher risk of developing HPV-associated cervical cancer. [More]
Seven NIH research contracts awarded to identify novel adjuvant candidates

Seven NIH research contracts awarded to identify novel adjuvant candidates

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded seven research contracts to discover and characterize new adjuvants, or substances formulated as part of vaccines to enhance their protective ability. [More]

Montefiore-Einstein selected to conduct multi-site cancer clinical trials

Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine of Yeshiva University have been awarded a $3.4 million grant from the National Cancer Institute to conduct multi-site cancer clinical trials and research focused on reducing healthcare disparities in cancer care. [More]